Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07054320 · ClinicalTrials.gov registry record
Rapamycin and Infection-related Illness
A clinical trial of Infectious Diseases, sponsored by Hoskinson Health and Wellness Clinic.
- Active
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT07054320: Active study of Infectious Diseases, sponsored by Hoskinson Health and Wellness Clinic.
NCT07054320 is a study of Infectious Diseases that is active but no longer recruiting, run by Hoskinson Health and Wellness Clinic. The registered enrollment target is 15 participants, below the 847-participant average among 4 other Infectious Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07054320, a study of Infectious Diseases, is active but no longer recruiting, sponsored by Hoskinson Health and Wellness Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Conduct a 6-month observational pilot clinical trial to evaluate the safety, monitor the adverse reactions and observe the preliminary effectiveness of medical treatment with oral rapamycin \[Rapamune (Sirolimus)\] in a total of 15 adults, 18 years and older toward preventing and lowering the severity of infectious disease or infection-related illness. Rapamune (Sirolimus) is not approved by the United States Food and Drug Administration (FDA) to prevent and lessen the severity of infection-related illness or infectious disease. Rapamune (Sirolimus) is approved by the FDA for other indications. The main procedures in the study include: * Blood tests to examine cholesterol, lipids, blood platelet counts, inflammation and infection-related health parameters * Questionnaires to examine brain function, mental health, symptoms, overall health status and quality of life * Electrocardiogram (ECG to measure heart function) * Resting diastolic and systolic blood pressure
Primary Outcome
The Primary Endpoint is the incidence and severity of infectious disease or infection-related illness prior to and 3 and 6 months following the initiation of the observational study measured by: * CBC * WBC * Neutrophils * Lymphocytes * Eosinophils * Basophils * Monocytes * CRP * PCT * ESR * ANC * Incidence of infection-related hospitalizations
Conditions Studied
Interventions
- OTHER Observational procedures
Study Locations (1)
Wyoming
- Hoskinson Health and Wellness Clinic - Gillette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-06 |
| Est. Completion | 2026-06 |
What the registry record for NCT07054320 still lists
NCT07054320 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 847-participant average among 4 other Infectious Diseases trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Infectious Diseases appearing as the primary indexed condition, and to 1 intervention - of which Observational procedures is the first listed.
NCT07054320 reports a single indexed study location in Wyoming.
Frequently Asked Questions
What is clinical trial NCT07054320 about?
NCT07054320 is a clinical study titled "Rapamycin and Infection-related Illness". Conduct a 6-month observational pilot clinical trial to evaluate the safety, monitor the adverse reactions and observe the preliminary effectiveness of medical treatment with oral rapamycin \[Rapamune (Sirolimus)\] in a total of 15 adults, 18 years and older toward preventing and lowering the severi...
What is the current status of trial NCT07054320?
This trial is currently active not recruiting. The enrollment target is 15 participants. The study started on 2025-08-06. Estimated completion is 2026-06.
What conditions does trial NCT07054320 study?
This clinical trial studies the following conditions: Infectious Diseases.
What interventions are being tested in trial NCT07054320?
The interventions under investigation include: Observational procedures (OTHER).
Who is sponsoring clinical trial NCT07054320?
This trial is sponsored by Hoskinson Health and Wellness Clinic, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07054320 being conducted?
This trial has 1 study location across Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infectious Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
RECRUITING
-
A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
ACTIVE NOT RECRUITING · Phase 2
-
Specificity Study of Diagnostic for Chagas Disease
COMPLETED
-
Specificity Study of Diagnostic for Early Detection of Dengue Infection
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI